Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma

Affiliations

• ¹ Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre.
• ² Department of Immunohematology, AP-HP, Hôpital Saint-Louis, Paris.
• ³ Department of Biophysics and Nuclear Medicine-Molecular Imaging, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, 91401.
• ⁴ Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre.
• ⁵ Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre. raphaele.seror@aphp.fr.